- Home
- VRE vs IMTX Comparison
VRE vs IMTX Comparison
Compare VRE & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRE | IMTX |
|---|---|---|
| Founded | 1949 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRE | IMTX |
|---|---|---|
| Price | $18.94 | $10.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $19.50 | $19.00 |
| AVG Volume (30 Days) | ★ 1.2M | 491.1K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 420.00 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $288,434,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.87 | $45.15 |
| P/E Ratio | $23.69 | ★ N/A |
| Revenue Growth | ★ 6.40 | N/A |
| 52 Week Low | $13.69 | $3.30 |
| 52 Week High | $18.97 | $12.41 |
Technical Indicators
Market Signals| Indicator | VRE | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 73.85 | 58.06 |
| Support Level | $18.83 | $9.05 |
| Resistance Level | $18.97 | $10.64 |
| Average True Range (ATR) | 0.05 | 0.53 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 85.72 | 80.00 |
Price Performance
Historical ComparisonAbout VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.